Gts Securities LLC Prothena Corp Public LTD CO Put Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$19.54 - $26.15 $19,540 - $26,150
1,000 Added 9.35%
11,700 $241,000
Q1 2024

May 15, 2024
SELL
$24.75 - $40.66 $59,400 - $97,583
-2,400 Reduced 18.32%
10,700 $265,000
Q4 2023

Feb 14, 2024
BUY
$32.31 - $52.32 $423,261 - $685,392
13,100 New
13,100 $476,000

Others Institutions Holding PRTA

# of Institutions
182
Shares Held
42.7M
Call Options Held
77.7K
Put Options Held
92.7K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $940M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email